Home › NDC Lookup › Ingredients › Ivermectin › 51672-4230-08
Ivermectin 5 mg/g Lotion — NDC 51672-4230-08 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Ivermectin 5 mg/g Lotion — NDC 51672-4230-8 (Billing 51672-4230-08)

by Sun Pharmaceutical Industries, Inc. · 1 TUBE in 1 CARTON / 117 g in 1 TUBE

This is a package of Ivermectin 5 mg/g Lotion from Sun Pharmaceutical Industries, Inc., marketed since May 2020 and currently FDA-listed; retail pharmacies pay about $1.24 per g (NADAC). It is this product's only package size.

NDC 51672-4230-08
🏷️ FDA NDC (as labeled) 51672-4230-8 billing pads the package segment with a zero
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 51672-4230-8
Product NDC 51672-4230
11-digit billing NDC 51672423008
NCPDP billing unit GM — per gram (weight)
RxCUI 1246673
UNII 8883YP2R6D
Application # ANDA210720
SPL Set ID dd2c66e6-bd50-46df-a335-26215d02d13b
Established class (EPC) Antiparasitic; Pediculicide
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-05-06
Route TOPICAL
Dosage form LOTION
Substance IVERMECTIN

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90900017004120
GPI class Ivermectin
GCN Seq No 068579
GCN 31394
HICL code 010933
Ingredient (HICL) Ivermectin
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5R
Therapeutic class — specific (HIC3) Topical Antiparasitics
AHFS code 84:04.12.00
AHFS class Scabicides And Pediculicides
FDB label name IVERMECTIN 0.5% LOTION
FDB brand name Ivermectin
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 068579
  • GCN: 31394
  • GPI-14 (Medi-Span): 90900017004120
  • HICL (First Databank): 010933
  • AHFS class code: 84:04.12.00
  • RxCUI (RxNorm): 1246673
Why two NDCs? The FDA registers this code as 51672-4230-8 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 51672-4230-08. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Antiparasitic class.

Pharmacologic class Antiparasitic, Pediculicide
Drug family (ATC) Other dermatologicals, Avermectines
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name IVERMECTIN 0.5% LOTION Ingredient Ivermectin
📖 What it is MedlinePlus · NLM

Ivermectin lotion is used to treat head lice (small bugs that attach themselves to the skin) in adults and children 6 months of age and older. Ivermectin is in a class of medications called anthelmintics. It works by killing lice.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Tablets treat intestinal strongyloidiasis and onchocerciasis. Lotions treat head lice, and the cream treats the bumps and pimples of rosacea.
  • Stromectol and ivermectin tablets are usually a single dose based on your weight. Take it on an empty stomach with water. Your doctor may order follow-up stool tests to confirm the...
  • Apply it to dry hair and scalp, covering everything from the scalp outward. Leave it on for 10 minutes, then rinse with water only. Wait 24 hours before shampooing, and don't reuse...
  • Dizziness, itching, rash, nausea, diarrhea, and tiredness were reported. If you're treated for onchocerciasis, fever, swollen glands, and joint pain can happen as the parasites die...
📖 Read our full Ivermectin guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $1.239 $145.01 / 117 g
Medicaid paysCMS SDUD · 12 mo $1.24 $144.88 / 117 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $1.305 $1.140
▲ Up 2% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
51672-4230-08 You're viewing this Main listing 1 TUBE in 1 CARTON / 117 g in 1 TUBE 2021-01-06 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Sklice 5 mg/g 24338-0185-04 Azurity 1 tube $0.285 — Availability likely save 77%
Ivermectin 5 mg/gthis 51672-4230-08 Sun 1 tube $1.239 — Availability likely —
Ivermectin 5 mg/g 00363-4230-08 Walgreen 1 tube — — FDA listed —
Ivermectin 5 mg/g 11822-4230-08 Rite 1 tube — — FDA listed —
Ivermectin 5 mg/g 27854-0334-01 Belmora 1 tube — — FDA listed —
Ivermectin 5 mg/g 46122-0827-36 AmerisourceBergen 1 tube — — FDA listed —
Ivermectin 5 mg/g 51316-0423-08 CVS 1 tube — — FDA listed —
Ivermectin 5 mg/g 51316-0985-08 CVS 1 tube — — FDA listed —
Ivermectin 5 mg/g 79903-0154-01 WALMART 1 tube — — FDA listed —
RID One and Done 5 mg/g 82392-0200-04 Oystershell 1 tube — — FDA listed —
lice treatment dedicated .5 g/100g 87276-0000-01 Shenzhen 1 g — — Discontinued —
lice treatment dedicated .5 g/100g 87276-0001-01 Shenzhen 1 g — — Discontinued —
ivometn ivermectin lice treatment .5 g/100g 87276-0003-01 Shenzhen 1 g — — Discontinued —
SYNTHABIO Ivermectin .5 g/100g 87782-0001-02 Shenzhen 1 tube — — FDA listed —
Ivermectin 5 mg/g 24338-0119-45 Azurity 1 tube — — FDA listed —
Ivermectin 5 mg/g 73581-0021-04 YYBA 1 tube — — FDA listed —
Ozipco Ivermectin 5 mg/g 86241-0113-01 Fast 1 tube — — FDA listed —
Vivoclear lvermectin Lice Treatment 5 mg/g 88025-0001-01 Guangxi 117 g — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
May 2020
📍
2026
Currently FDA-listed
6 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerSun Pharmaceutical Industries, Inc.
Application holderTARO PHARMACEUTICAL INDUSTRIES LTD
FDA applicationANDA210720 (ANDA)
Labeler code51672
First marketedMay 2020
Product typeHuman Otc Drug
Portfolio890 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Very long sections are excerpted here and marked; the full text is on DailyMed (linked in the sources below). Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 💬 Patient Medication Information 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 4 words ▾

Use treats head lice

⏱️ Dosage and Administration ~2 min read ▾

Directions Important: Read warnings before use children 6 months of age to under 12 years of age: an adult should supervise use adults and children 6 months of age and over: Inspect all household members should be checked by another person for lice and/or nits (eggs) use a magnifying glass in bright light to help you see the lice and/or nits (eggs) use a tool, such as a comb or two unsharpened pencils to lift and part the hair look for tiny nits near the scalp, beginning at the back of the neck and behind the ears examine small sections of the hair (1-2 inches wide) at a time unlike dandruff, nits stick to the hair.

Dandruff should move when lightly touched. if either lice or nits (eggs) are found, treat with product Treat your hair and scalp must be DRY before applying product use the top of cap to break the tamper seal on the tube apply product directly to dry hair and scalp completely cover your scalp and hair closest to the scalp first, and then apply outwards towards the ends of your hair use only amount needed to completely cover hair and scalp, up to 1 entire tube, and discard the remaining rub product throughout your hair it is important to completely cover your entire head so that all lice and eggs are exposed to the lotion.

Be sure that each hair is coated from the scalp to the tip. Wait and rinse allow product to stay on your hair and scalp for 10 minutes after it has been applied. Use a timer or clock.

Start timing after you have completely covered your hair and scalp with product. after 10 minutes, rinse product completely from your hair and scalp using only water after rinsing, dry and style as usual. Wait 24 hours before applying shampoo. After treatment wash your hands after applying product nit combing is not necessary when treating with product for it to work, but if desired, a fine-tooth comb or special nit comb may be used to remove dead lice and nits this is a single use product.

Discard tube after use. do not use again on the same person and same lice infestation without talking to a healthcare provider first if infestation continues, see a doctor for other treatments machine wash any bedding and clothing used by anyone having lice. Machine wash at high temperatures (150°F) and tumble in a hot dryer for 20 minutes. after finishing treatment with lice medicine, check everyone in your family for lice after one week. Consider treatment for those who have lice.

⚠️ Warnings 192 words ▾

Warnings For external use only. Use only on the scalp. Do not use on children under 6 months of age near the eyes inside the nose, ear, mouth, or vagina on lice in eyebrows or eyelashes.

See a doctor if lice are present in these areas. Ask a doctor before use if you have any skin conditions or sensitivities are pregnant or plan to become pregnant. It is not known if product can harm your unborn baby. are currently or planning to breastfeed.

Avoid getting product on your breast to help prevent contact by your baby. When using this product keep eyes tightly closed and protect eyes with a washcloth or towel if product gets into eyes, gently flush with water eye redness, soreness, or irritation can occur dandruff, dry skin, or burning sensation of the skin can occur Stop use and ask a doctor if breathing difficulty occurs eye irritation occurs skin or scalp irritation continues or infection occurs rash develops If pregnant or breastfeeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📦 Storage and Handling 37 words ▾

Other information TAMPER EVIDENT: DO NOT USE IF THE TAMPER SEAL ON THE TUBE HAS BEEN BROKEN. store at room temperature 68º-77ºF (20º-25ºC) do not freeze keep carton and see Consumer Information Leaflet and warnings before use

🧪 Active Ingredient 4 words ▾

Active ingredient Ivermectin 0.5%

🧪 Inactive Ingredients 38 words ▾

Inactive ingredients butylated hydroxyanisole, castor oil, cetyl alcohol, citric acid anhydrous, crodalan AWS, cyclomethicone, glycerin, imidurea, lanolin alcohols, methylparaben, oleyl alcohol, olive oil, propylene glycol, propylparaben, purified water, shea butter, sodium citrate anhydrous, sorbitan tristearate and stearyl alcohol.

🎯 Purpose 3 words ▾

Purpose Lice treatment

💬 Patient Medication Information ~3 min read ▾

Ivermectin Lotion, 0.5% Lice Treatment Lotion THE FACTS OF LICE Please read all information before using Ivermectin Lotion. If you or a member of your household has head lice, don't panic. Keep calm.

Anyone can get head lice – it has nothing to do with cleanliness or poor hygiene. Head lice are treatable and very rarely cause serious health problems. What are head lice?

Head lice are small insects that live and feed on the human scalp. They may get as big as sesame seeds and are brown. Lice do not fly or jump from one person to another.

They can only crawl. What are nits? Nits are lice eggs laid on the hair near the scalp.

One louse may lay over 100 nits. Nits are oval shaped, tiny and greyish-white. They are attached to hair with a waterproof glue-like substance that cannot be washed out or blown away.

How do head lice spread? Head lice spread easily from close head-to-head or hand-to-head contact with persons who have lice. They may also be spread by sharing hats, helmets, scarves, headphones, brushes, combs, bedding and clothing.

How do you know if you have lice? Itching is the most common symptom. Scratching behind the ears or the back of the neck is a sign that you should check for head lice.

Scabs or blood spots may be seen. How do you prevent the spread of lice? Avoid direct head-to-head contact with anyone known to have live, crawling lice.

Do not share combs, brushes, hats, scarves, bandannas, ribbons, barrettes, hair bands, towels, helmets, or other hair-related personal items with anyone else, whether they have lice or not. Avoid sleepovers and slumber parties during lice outbreaks. Lice can live in bedding, pillows, and carpets that have recently been used by someone with lice.

How do I use Ivermectin Lotion? Important: Read warnings before use Children 6 months of age to under 12 years of age: an adult should supervise use Adults and children 6 months of age and over: Inspect All household members should be checked by another person for lice and/or nits (eggs). Use a magnifying glass in bright light to help you see the lice and/or nits (eggs).

Use a tool, such as a comb or two unsharpened pencils to lift and part the hair. Look for tiny nits near the scalp, beginning at the back of the neck and behind the ears. Examine small sections of the hair (1-2 inches wide) at a time.

Unlike dandruff, nits stick to the hair. Dandruff should move when lightly touched. If either lice or nits (eggs) are found, treat with product.

Treat Your hair and scalp must be DRY before applying product. Figure A Use the top of cap to break the tamper seal on the tube (see Figure A ). Apply product directly to dry hair and scalp (see Figure B ).

Completely cover your scalp and hair closest to the scalp first, and then apply outwards towards the ends of your hair (see Figure C ). Use only amount needed to completely cover hair and scalp, up to 1 entire tube, and discard the remaining. Rub product throughout your hair (see Figure D ).

Figure B Figure C Figure D It is important to completely cover your entire head so that all lice and eggs are exposed to the lotion. Be sure that each hair is coated from the scalp to the tip. Wait and rinse Allow product to stay on your hair and scalp for 10 minutes after it has been applied.

Use a timer or clock. Start timing after you have completely covered your hair and scalp with product (see Figure E ). After 10 minutes, rinse product completely from your hair and scalp using only water (see Figure F ).

Figure E Figure F After rinsing, dry and style as usual. Wait 24 hours before applying shampoo. After treatment Wash your hands after applying product.

Nit combing is not necessary when treating with product for it to work, but if desired, a fine-tooth comb or special nit comb may be used to remove dead lice and nits. This is a single use product. Discard tube after use.

Do not use again on the same person and same lice infestation without talking to a healthcare provider first. If infestation continues, s… [Excerpted — this section continues on DailyMed.]

📄 Do Not Use 36 words ▾

Do not use on children under 6 months of age near the eyes inside the nose, ear, mouth, or vagina on lice in eyebrows or eyelashes. See a doctor if lice are present in these areas.

📄 Ask a Doctor Before Use If 50 words ▾

Ask a doctor before use if you have any skin conditions or sensitivities are pregnant or plan to become pregnant. It is not known if product can harm your unborn baby. are currently or planning to breastfeed. Avoid getting product on your breast to help prevent contact by your baby.

📄 When Using This Product 43 words ▾

When using this product keep eyes tightly closed and protect eyes with a washcloth or towel if product gets into eyes, gently flush with water eye redness, soreness, or irritation can occur dandruff, dry skin, or burning sensation of the skin can occur

📄 Stop Use and Ask a Doctor If 23 words ▾

Stop use and ask a doctor if breathing difficulty occurs eye irritation occurs skin or scalp irritation continues or infection occurs rash develops

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breastfeeding, ask a health professional before use.

📄 Keep Out of Reach of Children 20 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📄 Questions or Comments 2 words ▾

Questions? 1-866-923-4914

📄 Package Label / Principal Display Panel 75 words ▾

PRINCIPAL DISPLAY PANEL - 117 g Tube Carton Compare to the active ingredient in Sklice ® NDC 51672-4230-8 Ivermectin Lotion, 0.5% Lice Treatment Original Prescription Strength Now available without a prescription! One tube, one time, 10 minutes! IVERMECTIN LOTION KILLS LICE No nit combing required No second application required Includes: 1 Tube Net Wt. 4 oz (117 g) PRINCIPAL DISPLAY PANEL - 117 g Tube Carton

PRINCIPAL DISPLAY PANEL - 117 g Tube Carton Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
2.8K
Units reimbursed last 4 qtrs
328.9K
Gross reimbursed last 4 qtrs
$407.3K
Avg / prescription
$146.45
Avg / unit
$1.2383
Latest quarter Q1 2026
644Rx
Medicaid pays / g
$1.2383
gross reimbursed
vs
NADAC / g
$1.2394
acquisition cost
=
Spread
−$0.0011
+0% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
48% FFS 52% MCO
Fee-for-service · 1,338 Rx Managed care · 1,443 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 1,521 units · 26.5 per 100k residents MN Wisconsin: no data reported WI Michigan: 42,822 units · 427 per 100k residents MI New York: 89,856 units · 459 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 6,201 units · 146 per 100k residents OR Nevada: 1,521 units · 47.6 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: 7,722 units · 59.6 per 100k residents PA New Jersey: 4,446 units · 47.9 per 100k residents NJ Massachusetts: 8,658 units · 124 per 100k residents MA California: 16,385 units · 42.1 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: 17,199 units · 197 per 100k residents VA Maryland: 6,202 units · 100 per 100k residents MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 2,457 units · 33.1 per 100k residents AZ New Mexico: no data reported NM Kansas: 54,993 units · 1,871 per 100k residents KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 15,210 units · 283 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: 4,800 units · 163 per 100k residents MS Alabama: 41,301 units · 809 per 100k residents AL Georgia: 1,521 units · 13.8 per 100k residents GA D.C.: no data reported DC Hawaii: 6,084 units · 424 per 100k residents HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
13.81,871
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Kansas 1,871 /100k
2 Alabama 809 /100k
3 New York 459 /100k
4 Michigan 427 /100k
5 Hawaii 424 /100k
6 South Carolina 283 /100k
7 Virginia 197 /100k
8 Mississippi 163 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for IVermectin — the program that covers self-administered drugs. 7 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name IVermectin. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$3.22M
Claims incl. refills
25.2K
Beneficiaries
20.3K
Spend / beneficiary
$158.78
Spend / claim
$128.08
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
← 51672-4228-04 · Sun 51672-4233-01 · Sun →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.